Chin Peter Scott's Form 4 filing
Denali Therapeutics Inc. (DNLI) · filed Sep 9, 2026
- Accession no.
- 0002124755-26-000007
- Filed
- Sep 9, 2026, 4:44 PM ET
- Trade date
- Sep 4, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $36.9K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chin Peter ScottCIK 0002124755 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Common Stock | SSaleDisposed | −1,654 | $22.29 | −$36,867.66 | 204,538 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.